Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Jennifer Gao | Researchclopedia

Back to researchers

Jennifer Gao

United States Food and Drug Administration ORCID

61

Works

1,771

Citations

17

h-index

21

i10-index

Research Topics

Advanced Breast Cancer Therapies Cancer Treatment and Pharmacology Breast Cancer Treatment Studies

Affiliations

National Institutes of Health2011–2018

United States Food and Drug Administration2018–2026

Amgen (United States)2013–2013

Center for Drug Evaluation and Research2019–2024

Harvard University2017–2017

Top Works

CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis

Jennifer Gao,Joyce Cheng,et al.

2019290 citations

Health Systems, Economic Evaluations, Quality of Life

HER2/EGFR in Cancer Research

Luminal A Breast Cancer and Molecular Assays: A Review

Jennifer Gao,Sandra M. Swain

2018244 citations

Dopamine agonists and risk: impulse control disorders in Parkinson's; disease

Valerie Voon,Jennifer Gao,et al.

2011205 citations

FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer

Shaily Arora,Sanjeeve Balasubramaniam,et al.

2020179 citations

FDA Approval Summary: Atezolizumab Plus Paclitaxel Protein-bound for the Treatment of Patients with Advanced or Metastatic TNBC Whose Tumors Express PD-L1

Preeti Narayan,Sakar Wahby,et al.

2020179 citations

FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer

Preeti Narayan,Tatiana M. Prowell,et al.

2020161 citations

Outcomes of Older Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer Treated With a CDK4/6 Inhibitor and an Aromatase Inhibitor: An FDA Pooled Analysis

Lynn Howie,Harpreet Singh,et al.

201987 citations

U.S. FDA Drug Approvals for Breast Cancer: A Decade in Review

Shaily Arora,Preeti Narayan,et al.

202166 citations

FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase–zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer

Jennifer Gao,Christy Osgood,et al.

202043 citations